RPS3AP7

Across TCGA pan-cancer cohorts, RPS3AP7 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated RPS3AP7 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RPS3AP7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS3AP7 expression acts as an unfavorable survival marker, although some lineages such as CESC and KIRC show a favorable association.

OV, CESC, and KIRC are the cancer types where RPS3AP7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Median	III,IV	0.261	0.370	.002	42	view →
CESC	OS	Quartile	All	0.875	0.481	.001	36	view →
KIRC	OS	Median	All	0.718	0.549	<.001	34	view →
UCEC	DFS	Tertile	All	0.530	0.756	.022	26	view →
LGG	OS	Median	All	0.933	0.836	<.001	19	view →
THCA	DFS	Median	All	0.931	0.858	.003	19	view →
UVM	DFS	Quartile	All	0.272	0.906	.017	16	view →
KICH	DFS	Tertile	All	0.706	1.000	.025	16	view →
ACC	OS	Tertile	II,III,IV	0.692	0.964	.024	15	view →
LIHC	OS	Quartile	II,III,IV	0.547	0.760	.012	15	view →
CHOL	DFS	Tertile	All	0.132	0.533	.004	12	view →
LUAD	DFS	Median	All	0.733	0.623	.028	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

RPS3AP7–OV (OS)

Open the OV breakdown →